You are here

COVID-19

Vaccine registration technology is failing. Here’s how the Biden administration could fix it

Vaccine registration technology is failing. Here’s how the Biden administration could fix it

Stat

Flag link:

Biotech startup raises $25M for cancer, Covid-19 vaccines

Biotech startup raises $25M for cancer, Covid-19 vaccines

MedCity News

Aivita Biomedical

cancer vaccines

Flag link:

5 questions facing the FDA in 2021

5 questions facing the FDA in 2021

BioPharma Dive

clinical trials

Flag link:

Johnson & Johnson Expects Vaccine Results Soon but Lags in Production

Johnson & Johnson Expects Vaccine Results Soon but Lags in Production

NY Times, NY

Flag link:

Bold Predictions for Medtech in 2021

Bold Predictions for Medtech in 2021

Medical Devices and Diagnostics Industry

remote patient monitoring

digital medicine

artificial intelligence

machine learning

robotic surgery

Flag link:

JPM: How did Pfizer up its COVID-19 vaccine capacity? 'Out of the box manufacturing,' CEO says

JPM: How did Pfizer up its COVID-19 vaccine capacity? 'Out of the box manufacturing,' CEO says

Fierce Pharma

drug manufacturing

Flag link:

Data fuel debate over whether J&J’s one-dose Covid vaccine will measure up

Data fuel debate over whether J&J’s one-dose Covid vaccine will measure up

Stat

clinical trials

Flag link:

US to pay up to $2.6B for more doses of Regeneron's COVID-19 antibody drug

US to pay up to $2.6B for more doses of Regeneron's COVID-19 antibody drug

BioPharma Dive

government contracts

Flag link:

Are face-to-face medical meetings a thing of the past?

Are face-to-face medical meetings a thing of the past?

Pharmaforum

virtual meetings

Flag link:

JPM: CureVac's new pharma partner Bayer says its COVID-19 vaccine not just an also-ran

JPM: CureVac's new pharma partner Bayer says its COVID-19 vaccine not just an also-ran

Fierce Biotech

Flag link:

COVID-19 in the ER? Level Ex uses J&J grant to simulate infections in medical education video games

COVID-19 in the ER? Level Ex uses J&J grant to simulate infections in medical education video games

Fierce Pharma

Flag link:

Celltrion's COVID-19 antibody improves outcomes in phase 2

Celltrion's COVID-19 antibody improves outcomes in phase 2

Fierce Biotech

clinical trials

Flag link:

‘No going back’ for clinical trials after COVID

‘No going back’ for clinical trials after COVID

Pharmaforum

clinical trials

virtual clinical trials

Flag link:

Moncef Slaoui to step down from Operation Warp Speed in a month — report

Moncef Slaoui to step down from Operation Warp Speed in a month — report

Endpoints

Operation Warp Speed

Flag link:

JPM: Lilly, Moderna, insitro CEOs say pandemic forced R&D, marketing and ops changes worth keeping

JPM: Lilly, Moderna, insitro CEOs say pandemic forced R&D, marketing and ops changes worth keeping

Fierce Pharma

Stephane Bancel

Flag link:

Moderna and Uber Teaming Up on Coronavirus Vaccine Awareness Push

Moderna and Uber Teaming Up on Coronavirus Vaccine Awareness Push

Motley Fool

Moderna Therapeutics

Flag link:

Oral COVID-19 vaccine beckons, as ImmunityBio licenses iosBio tech

Oral COVID-19 vaccine beckons, as ImmunityBio licenses iosBio tech

Pharmaforum

Flag link:

Gilead Updates 2020 Guidance with Post-Holiday COVID-19 Spike

Gilead Updates 2020 Guidance with Post-Holiday COVID-19 Spike

BioSpace

Gilead Sciences

Flag link:

JPM21: Vaccines soar, antibodies struggle as COVID-19 drugs become a business

JPM21: Vaccines soar, antibodies struggle as COVID-19 drugs become a business

BioPharma Dive

Flag link:

JPM Week: Will the first COVID-19 vaccines deter future launches? Not at all, experts say

JPM Week: Will the first COVID-19 vaccines deter future launches? Not at all, experts say

Fierce Pharma

Flag link:

Pages